Results 121 to 130 of about 10,444 (219)

Efficacy, safety and tolerability of mometasone furoate 0.1% cream, ointment and lotion in childhood eczema

open access: yes, 2016
Background Topical corticosteroids have been the first line treatment in children with eczema. Efforts to develop new topical glucocorticoids with reduce systemic bioactivity help to treat them. Mometasone furoate 0.1% has been found to be efficacious in
Naseema Kapadia, Saima Ghouri
core   +1 more source

Response of cutaneous microcirculation to treatment with mometasone furoate in patients with psoriasis

open access: yes, 2009
Background. In patients with psoriasis, videocapillaroscopy has been used to visualize the typical modifications in the microcirculatory architecture. Aim.
VALENT, Francesca   +4 more
core   +1 more source

Mometasone Furoate and Nasal Vascularisation in Allergic Patients

open access: yesCollegium antropologicum, 2013
Angiogenesis, the growth and proliferation of new blood vessels, is important in a variety of pathophysiological processes. However the role of angiogenesis in allergic rhinitis has not been well studied. Hence, the aim of this study was to compare the vascularisation of the nasal mucous membrane of non-allergic, non-treated allergic and allergic ...
Kujundzic, Milodar   +5 more
openaire   +4 more sources

Efficacy of Intranasal Mometasone Furoate as an Add on Therapy in the Treatment of Adenoidal Hypertrophy in Adolescents [PDF]

open access: yes, 2017
INTRODUCTION: Adenoidal hypertrophy is an important cause for nasal symptoms in adolescent patients. Encouraging results were reported with the use of intranasal steroids in adolescent patients.
San Anbu Sahayam, J
core  

THE EFFECT OF DECONGESTANTS AND TOPICAL STEROIDS ON THE NASAL BREATHING AND NASAL CYCLE

open access: yesСеченовский вестник, 2017
We registered nasal cycles and the mucociliary transport time in 40 adults: 20 men (18-71) and 20 women (18-70) with acute rhinosinusitis. Subjects had no signs of other systems’ pathologies, bad habits and other ENT organs’ diseases.
V. Shilenkova, O. V. Fedoseeva
doaj  

Home - About - Disclaimer - Privacy